Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Gannett Co. Q4 Profit Declines - Quick Facts

RELATED NEWS
Trade GCI now with 

Gannett Co. Inc. (GCI: Quote) said Monday fourth-quarter profit fell to $116.9 million, or $0.49 per share, from $174.1 million, or $0.72 per share, a year ago. Adjusted earnings were $0.72 per share in the recent quarter and $0.83 per share last year.

Eight analysts polled by Thomson Reuters estimated earnings of $0.68 per share. Analysts' estimates usually exclude special items.

Revenues for the period were $1.39 billion, compared to the prior-year's $1.46 billion, as a result of a 7.1 percent drop in publishing advertising revenues and a 14.2 percent drop in broadcasting revenues. Seven analysts polled by Thomson Reuters estimated revenues of $1.39 billion.

Click here to receive FREE breaking news email alerts for Gannett Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
With disappointing earnings news generating some selling pressure, stocks have moved mostly lower in early trading on Friday. The major averages have slid firmly into negative territory after ending the previous session nearly flat. After reporting an unexpected drop in new orders for U.S. manufactured durable goods in the previous month, the Commerce Department released a report on Friday showing that durable goods orders rebounded by more than expected in the month of June. British economic growth remained high as expected in the second quarter as a robust expansion in the dominant service sector, and industry completely offset the slight weakness in the construction sector. With the second quarter expansion, GDP returned to its pre-crisis level. Gross domestic product grew 0.8 percent sequentially in the second quarter, the same rate as seen in the first quarter.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.